Literature DB >> 9402460

C-reactive protein and complement in myocardial infarction and postinfarction heart failure.

J T Beranek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9402460     DOI： 10.1093/oxfordjournals.eurheartj.a015180

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  9 in total

1.  Tissue factor identifies cardiomyocyte apoptotic bodies in reperfusion injury.

Authors:  Jiri T Beranek
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

2.  Complement anaphylatoxin C3a as a novel independent prognostic marker in heart failure.

Authors:  Tímea Gombos; Zsolt Förhécz; Zoltán Pozsonyi; Gábor Széplaki; Jan Kunde; George Füst; Lívia Jánoskuti; István Karádi; Zoltán Prohászka
Journal:  Clin Res Cardiol       Date:  2012-02-29       Impact factor: 5.460

3.  C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction.

Authors:  M Griselli; J Herbert; W L Hutchinson; K M Taylor; M Sohail; T Krausz; M B Pepys
Journal:  J Exp Med       Date:  1999-12-20       Impact factor: 14.307

Review 4.  Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons.

Authors:  Jan Torzewski; Patrizia Brunner; Wolfgang Ries; Christoph D Garlichs; Stefan Kayser; Franz Heigl; Ahmed Sheriff
Journal:  J Clin Med       Date:  2022-03-23       Impact factor: 4.241

Review 5.  Acute phase reactants as novel predictors of cardiovascular disease.

Authors:  M S Ahmed; A B Jadhav; A Hassan; Qing H Meng
Journal:  ISRN Inflamm       Date:  2012-05-06

6.  C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty.

Authors:  Christian Stumpf; Ahmed Sheriff; Stefan Zimmermann; Liane Schaefauer; Christian Schlundt; Dorette Raaz; Christoph D Garlichs; Stephan Achenbach
Journal:  Arch Med Sci       Date:  2017-08-03       Impact factor: 3.318

Review 7.  The Pentraxins 1975-2018: Serendipity, Diagnostics and Drugs.

Authors:  Mark B Pepys
Journal:  Front Immunol       Date:  2018-10-16       Impact factor: 7.561

Review 8.  Selective Apheresis of C-Reactive Protein for Treatment of Indications with Elevated CRP Concentrations.

Authors:  Stefan Kayser; Patrizia Brunner; Katharina Althaus; Johannes Dorst; Ahmed Sheriff
Journal:  J Clin Med       Date:  2020-09-12       Impact factor: 4.241

Review 9.  [CRP apheresis in acute myocardial infarction and COVID-19].

Authors:  Michael Buerke; Ahmed Sheriff; Christoph D Garlichs
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-03-25       Impact factor: 1.552
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.